Home >> Pharmaceuticals >> Food & Beverage >>

Global Helminthic Infestations Therapeutics Market Report 2018 - Industry Analysis, Size, Share, Trends, Segment and Forecasts to 2025

Published: Dec-2018 | Format: PDF | MAResearch | Number of pages: 134 | Code: MRS - 383645

The global Helminthic Infestations Therapeutics market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Helminthic Infestations Therapeutics from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Helminthic Infestations Therapeutics market.

Leading players of Helminthic Infestations Therapeutics including:
    Neural Analytics, Inc.
    M3 Biotechnology, Inc.
    Cerevance
    Mitochon Pharmaceuticals, Inc.
    Peptilogics
    Farmoquimica S/A
    biOasis Technologies, Inc.
    HCA Healthcare, Inc.
    Alzeca Biosciences, Inc.
    Johnson & Johnson

Market split by Type, can be divided into:
    Benzimidazole
    Pyrantel
    Piperazine Citrate
    Others

Market split by Application, can be divided into:
    Enterobius vermicularis
    Taenia saginata
    Ascaris lumbricoides
    Trichuris trichiura
    Others

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Helminthic Infestations Therapeutics Market Overview
    1.1 Helminthic Infestations Therapeutics Definition
    1.2 Global Helminthic Infestations Therapeutics Market Size Status and Outlook (2013-2028)
    1.3 Global Helminthic Infestations Therapeutics Market Size Comparison by Region (2013-2028)
    1.4 Global Helminthic Infestations Therapeutics Market Size Comparison by Type (2013-2028)
    1.5 Global Helminthic Infestations Therapeutics Market Size Comparison by Application (2013-2028)
    1.6 Global Helminthic Infestations Therapeutics Market Size Comparison by Sales Channel (2013-2028)
    1.7 Helminthic Infestations Therapeutics Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Helminthic Infestations Therapeutics Market Segment Analysis by Player
    2.1 Global Helminthic Infestations Therapeutics Sales and Market Share by Player (2016-2018)
    2.2 Global Helminthic Infestations Therapeutics Revenue and Market Share by Player (2016-2018)
    2.3 Global Helminthic Infestations Therapeutics Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Helminthic Infestations Therapeutics Market Segment Analysis by Type
    3.1 Global Helminthic Infestations Therapeutics Market by Type
        3.1.1 Benzimidazole
        3.1.2 Pyrantel
        3.1.3 Piperazine Citrate
        3.1.4 Others
    3.2 Global Helminthic Infestations Therapeutics Sales and Market Share by Type (2013-2018)
    3.3 Global Helminthic Infestations Therapeutics Revenue and Market Share by Type (2013-2018)
    3.4 Global Helminthic Infestations Therapeutics Average Price by Type (2013-2018)
    3.5 Leading Players of Helminthic Infestations Therapeutics by Type in 2017
    3.6 Conclusion of Segment by Type
Chapter 4 Helminthic Infestations Therapeutics Market Segment Analysis by Application
    4.1 Global Helminthic Infestations Therapeutics Market by Application
        4.1.1 Enterobius vermicularis
        4.1.2 Taenia saginata
        4.1.3 Ascaris lumbricoides
        4.1.4 Trichuris trichiura
        4.1.5 Others
    4.2 Global Helminthic Infestations Therapeutics Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Helminthic Infestations Therapeutics by Application in 2017
    4.4 Conclusion of Segment by Application
Chapter 5 Helminthic Infestations Therapeutics Market Segment Analysis by Sales Channel
    5.1 Global Helminthic Infestations Therapeutics Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Helminthic Infestations Therapeutics Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Helminthic Infestations Therapeutics by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Helminthic Infestations Therapeutics Market Segment Analysis by Region
    6.1 Global Helminthic Infestations Therapeutics Market Size and CAGR by Region (2013-2028)
    6.2 Global Helminthic Infestations Therapeutics Sales and Market Share by Region (2013-2018)
    6.3 Global Helminthic Infestations Therapeutics Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Helminthic Infestations Therapeutics Market Share by Type
        6.4.3 North America Helminthic Infestations Therapeutics Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Helminthic Infestations Therapeutics Market Share by Type
        6.5.3 Europe Helminthic Infestations Therapeutics Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Helminthic Infestations Therapeutics Market Share by Type
        6.6.3 Asia-Pacific Helminthic Infestations Therapeutics Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Helminthic Infestations Therapeutics Market Share by Type in 2017
        6.7.3 South America Helminthic Infestations Therapeutics Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Helminthic Infestations Therapeutics Market Share by Type
        6.8.3 Middle East & Africa Helminthic Infestations Therapeutics Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Helminthic Infestations Therapeutics Players
    7.1 Neural Analytics, Inc.
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 M3 Biotechnology, Inc.
    7.3 Cerevance
    7.4 Mitochon Pharmaceuticals, Inc.
    7.5 Peptilogics
    7.6 Farmoquimica S/A
    7.7 biOasis Technologies, Inc.
    7.8 HCA Healthcare, Inc.
    7.9 Alzeca Biosciences, Inc.
    7.10 Johnson & Johnson
Chapter 8 Upstream and Downstream Analysis of Helminthic Infestations Therapeutics
    8.1 Industrial Chain of Helminthic Infestations Therapeutics
    8.2 Upstream of Helminthic Infestations Therapeutics
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Helminthic Infestations Therapeutics
        8.3.1 Leading Distributors/Dealers of Helminthic Infestations Therapeutics
        8.3.2 Leading Consumers of Helminthic Infestations Therapeutics
Chapter 9 Development Trend of Helminthic Infestations Therapeutics (2018-2028)
    9.1 Global Helminthic Infestations Therapeutics Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global Helminthic Infestations Therapeutics Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global Helminthic Infestations Therapeutics Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global Helminthic Infestations Therapeutics Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global Helminthic Infestations Therapeutics Market Size Forecast by Sales Channel (2018-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2500 View Pricing